GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer
- Rugo, H.S.
- Cortes, J.
- Barrios, C.H.
- Cabrera, P.
- Xu, B.
- Huang, C.-S.
- Kim, S.-B.
- Melisko, M.
- Nanda, R.
- Pieńkowski, T.
- Rapoport, B.L.
- Schwab, R.
ISSN: 1744-8301, 1479-6694
Argitalpen urtea: 2022
Alea: 18
Zenbakia: 34
Orrialdeak: 3801-3813
Mota: Berrikuspena